Table 5. Absorption with SakSTAR... | American Society of Hematology

Table 5.

Absorption with SakSTAR variants of antibodies elicited with SakSTAR variants in patients with peripheral arterial occlusion (%)

Treatment	n	Absorbant	Insolubilized compound
Treatment	n	Absorbant	WT	SY19	SY141	SY145	SY151	SY155
WT	Pool 40	WT	+^A	+	+	+	+	+
		SY19	59	+	+	+	+	+
		SY141	24	45	+	66	70	59
		SY145	31	55	+	+	91	73
		SY151	34	54	90	84	+	70
		SY155	36	69	+	+	+	+
SY19	4	WT	94	92	+	+	+	+
		SY19	92	+^A	+	+	+	+
		SY141	41	70	90	85	88	86
		SY145	78	+	+	+	+	+
		SY151	80	+	+	+	+	+
		SY155	83	+	+	+	+	+
SY141	3	WT	87	+	+	94	+	+
		SY19	87	+	+	+	+	+
		SY141	53^B	72	85^A	80	77	78
		SY145	83	90	+	93	93	94
		SY151	81	85	+	+	+	+
		SY155	82	92	+	+	+	+
SY145	3	WT	+	+	+	93	92	92
		SY19	81	+	93	90	92	89
		SY141	66	73	79	76	77	78
		SY145	73^B	82	94	91^A	90	90
		SY151	71	78	93	88	88	88
		SY155	78	83	94	93	93	94
SY151	4	WT	+	+	+	+	+	+
		SY19	+	+	+	+	+	+
		SY141	83	83	93	92	93	89
		SY145	87	87	+	+	+	93
		SY151	88	91	+	+	+^A	94
		SY155	87	90	+	+	+	+
SY155	4	WT	+	+	+	+	+	+
		SY19	+	+	+	+	+	+
		SY141	84	87	+	89	89	90
		SY145	92	94	+	+	+	+
		SY151	92	94	+	+	+	+
		SY155	94	+	+	+	+	+^A

Treatment	n	Absorbant	Insolubilized compound
Treatment	n	Absorbant	WT	SY19	SY141	SY145	SY151	SY155
WT	Pool 40	WT	+^A	+	+	+	+	+
		SY19	59	+	+	+	+	+
		SY141	24	45	+	66	70	59
		SY145	31	55	+	+	91	73
		SY151	34	54	90	84	+	70
		SY155	36	69	+	+	+	+
SY19	4	WT	94	92	+	+	+	+
		SY19	92	+^A	+	+	+	+
		SY141	41	70	90	85	88	86
		SY145	78	+	+	+	+	+
		SY151	80	+	+	+	+	+
		SY155	83	+	+	+	+	+
SY141	3	WT	87	+	+	94	+	+
		SY19	87	+	+	+	+	+
		SY141	53^B	72	85^A	80	77	78
		SY145	83	90	+	93	93	94
		SY151	81	85	+	+	+	+
		SY155	82	92	+	+	+	+
SY145	3	WT	+	+	+	93	92	92
		SY19	81	+	93	90	92	89
		SY141	66	73	79	76	77	78
		SY145	73^B	82	94	91^A	90	90
		SY151	71	78	93	88	88	88
		SY155	78	83	94	93	93	94
SY151	4	WT	+	+	+	+	+	+
		SY19	+	+	+	+	+	+
		SY141	83	83	93	92	93	89
		SY145	87	87	+	+	+	93
		SY151	88	91	+	+	+^A	94
		SY155	87	90	+	+	+	+
SY155	4	WT	+	+	+	+	+	+
		SY19	+	+	+	+	+	+
		SY141	84	87	+	89	89	90
		SY145	92	94	+	+	+	+
		SY151	92	94	+	+	+	+
		SY155	94	+	+	+	+	+^A

Results represent mean values of n patients. Absorption ≥ 95% is represented by +. WT: wild-type SakSTAR. Code identification in Table 3. For an explanation of superscripts A and B, see “Absorption with SakSTAR variants of antibodies elicited in patients by treatment with SakSTAR variants.”

View Large

This Feature Is Available To Subscribers Only